Merck Reports Q4 EPS of $0.88

Merck & Co Inc MRK reports its Q4 EPS at $0.88, beating the consensus of $0.83. MRK reports its Q4 revenue at $12.09 billion, versus the consensus of $11.52 billion. MRK shares gained 0.03% to $33.83 in after-hours trading. Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsEarningsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!